LEGN Stock Analysis: Buy, Sell, or Hold?
LEGN - Legend Biotech Corporation American Depositary Shares
$25.75
-1.33 (-4.91%)
▼
5d:
-8.17%
30d:
-26.13%
90d:
+41.8%
HOLD
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 10, 2026
27d
Get Alerted When LEGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LEGN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: LEGN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$63.32
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$39.32
34.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LEGN is currently trading at $25.75, which is considered oversold relative to its 30-day fair value range of $27.59 to $33.65. From a valuation perspective, the stock is trading at a discount (Forward PE: 19.8) compared to its historical average (36.5). Remarkably, the market is currently pricing in an annual earnings decline of 18.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, LEGN is in a strong uptrend. The price is currently testing key support at $25.10. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $57.17 (+122.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LEGN is in a strong uptrend. The price is currently testing key support at $25.10. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $57.17 (+122.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$27.59 -
$33.65
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.9%)
- BULLISH: Trading 122.0% below Wall St target ($57.17)
- CAUTION: Recommendation downgraded due to -8.2% 5-day decline
Trading Range Analysis
30-Day Trading Range
$27.59 -
$33.65
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$25.10
Resistance Level
$30.27
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.80
Wall Street Target
$57.17
(+122.0%)
Revenue Growth (YoY)
56.5%
Profit Margin
-22.0%
Valuation Discount vs History
-18.4% cheaper
PE vs Historical
19.8 vs 36.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-18.4%
(market-implied from PE analysis)
1-Year Target
$23.18
(-10%)
2-Year Target
$20.86
(-19%)
3-Year Target
$18.77
(-27%)
3-Yr Target (if PE normalizes)
(PE: 20→37)
$34.61
(+34%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 364.5%)
$95.61
(+271%)
Base:
(SPY PE: 19.8, Growth: 364.5%)
$86.91
(+238%)
Bear:
(PE: 16.8, Growth: 364.5%)
$73.87
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.8 to 36.5
Stabilization Target:
$47.48
(+84.4%)
PE Expansion Potential:
+84.4%
Share & Embed Analysis
Last updated: July 13, 2026 5:39 PM ET
Data refreshes hourly during market hours. Next update: 6:39 PM
Data refreshes hourly during market hours. Next update: 6:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LEGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Ying Huang
SELL
9936 shares
2026-03-25
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1051 | 56 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 50 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$277 | 51 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$99 | 44 HOLD |
